Prof Peter Taylor (Oxford, UK) joins Dr David Liew to discuss results from the PERSIST study, a real-world, observational, prospective cohort study of CT-P13 for treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Read the paper here: https://doi.org/10.1093/rap/rkab026This episode was originally published in December 2021. Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, or tweet us @RheumJnl. Want to read more of our research? Explore Rheumatology and Rheumatology Advances in Practice.